AstraZeneca holds talks with US cancer drug developer in $400bn merger

Bristol Myers Squibb tie-up would be one of biggest-ever pharma deals and create world's fourth-largest drugmaker

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。